Privia Health Revenue 2020-2025 | PRVA

Privia Health revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Privia Health Annual Revenue
(Millions of US $)
2024 $1,736
2023 $1,658
2022 $1,357
2021 $966
2020 $817
2019 $786
Privia Health Quarterly Revenue
(Millions of US $)
2025-03-31 $480
2024-12-31 $461
2024-09-30 $438
2024-06-30 $422
2024-03-31 $415
2023-12-31 $441
2023-09-30 $417
2023-06-30 $413
2023-03-31 $386
2022-12-31 $364
2022-09-30 $343
2022-06-30 $336
2022-03-31 $314
2021-12-31 $275
2021-09-30 $252
2021-06-30 $226
2021-03-31 $214
2020-12-31 $214
2020-09-30 $207
2020-06-30 $183
2020-03-31 $213
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.041B $1.736B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.971B 53.83
Hims & Hers Health (HIMS) United States $11.505B 119.54
Tempus AI (TEM) United States $11.232B 0.00
Inspire Medical Systems (INSP) United States $4.506B 70.41
IRhythm Technologies (IRTC) United States $4.374B 0.00
Clover Health Investments (CLOV) United States $1.916B 0.00
Enovis (ENOV) United States $1.889B 10.53
Schrodinger (SDGR) United States $1.744B 0.00
Phreesia (PHR) United States $1.492B 0.00
Azenta (AZTA) United States $1.266B 58.96
Omnicell (OMCL) United States $1.189B 20.98
10x Genomics (TXG) United States $1.055B 0.00
Fulgent Genetics (FLGT) United States $0.565B 0.00
Butterfly Network (BFLY) United States $0.561B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.424B 0.00
TruBridge (TBRG) United States $0.374B 833.33
Claritev (CTEV) United States $0.350B 0.00
Health Catalyst (HCAT) United States $0.293B 0.00
Nyxoah SA (NYXH) Belgium $0.211B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
Pulmonx (LUNG) United States $0.147B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
American Well (AMWL) United States $0.109B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.086B 0.00
CareCloud (CCLD) United States $0.078B 2.97
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.057B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00